Mid-term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support.

ABSTRACT:

Background

Patients with end-stage heart failure and chronic kidney disease requiring dual-organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi-organ failure. Given the limited options available for long-term support in this patient population, there remains a critical need for alternative strategies to optimize end-organ function and bridge patients safely to transplant. With prolonged waitlist times for DOT, we present our experience with the Impella 5.5 as temporary mechanical circulatory support, demonstrating its potential to provide hemodynamic stability and support as a bridge to transplantation (BTT) in this complex cohort.

Methods

A si

SUBMITTER: Desai S 

PROVIDER: S-EPMC12719849 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature